Inverness Counsel’s ResMed RMD Stock Holding History

Inverness Counsel’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.55M	Buy	7,099 +410	+6%	+$93.3K	0.09%	71
2022 Q2	$1.4M	Sell	6,689 -20	-0.3%	-$4.26K	0.08%	66
2022 Q1	$1.63M	Buy	6,709 +2,856	+74%	+$691K	0.07%	70
2021 Q4	$1M	Buy	3,853 +24	+0.6%	+$6.23K	0.04%	87
2021 Q3	$1.01M	Buy	3,829 +1,815	+90%	+$496K	0.04%	88
2021 Q2	$496K	Buy	+2,014	New	+$423K	0.02%	114

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Inverness Counsel's RMD Position: Q3 2022 in Review

Inverness Counsel increased its ResMed (RMD) stake by 6.1% in Q3 2022, buying an estimated $93.3K and bringing the position to 7,099 shares worth $1.55M. The position accounts for 0.09% of the portfolio, ranked #71.

Inverness Counsel first reported a position in RMD in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.63M in Q1 2022. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

Inverness Counsel held 7,099 shares of ResMed worth $1.55M as of Q3 2022.
Inverness Counsel bought 410 ResMed shares in Q3 2022, an estimated $93.3K.
ResMed made up 0.09% of Inverness Counsel's portfolio in Q3 2022, its #71 holding.
Inverness Counsel first reported a position in ResMed in Q2 2021 and has held it in 6 quarters since.
Inverness Counsel's ResMed position peaked at $1.63M in Q1 2022.
668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.